BDSI’s Sirgo to Retire as CEO But Remain Vice Chairman

Xconomy Raleigh-Durham — 

Mark Sirgo, president and CEO of BioDelivery Sciences International (NASDAQ: BDSI), will retire at the end of the year, the Raleigh, NC, pharmaceutical company has announced. But Sirgo will remain vice chairman of BDSI’s board of directors. The company said that the board will work with Sirgo to find his successor. Sirgo, who has been president and CEO of BDSI since 2005, led the company to FDA approvals of treatments for chronic pain, cancer pain, and opioid dependence.